Application 200196
- Type
- ANDA
- Sponsor
- EMCURE PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE; ORAL | 300MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atazanavir Sulfate | ATAZANAVIR | Aurobindo Pharma Limited | 7fbea274-d6b5-4faa-bbf0-05fefab42114 | 2025-08-06 | Warnings, Adverse reactions | Atazanavir Sulfate |
| Atazanavir Sulfate | ATAZANAVIR SULFATE | Teva Pharmaceuticals USA, Inc. | 654b7e08-33d8-47e7-b37f-3681e79c7b8b | 2024-12-30 | Warnings, Adverse reactions | Atazanavir Sulfate ATAZANAVIR SULFATE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 9808 | ORIG | 2010-08-24 |